Camp4 Therapeutics Corp (CAMP)

$5.41 +0.03 (0.56%)
Market Cap 280.88M
Revenue (ttm) 3.50M
Net Income (ttm) -80.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,297.14%
Debt to Equity Ratio 0.00
Volume 107,500
Avg Vol 211,998
Day's Range N/A - N/A
Shares Out 51.92M
Stochastic %K 39%
Beta 0.36
Analysts Strong Sell
Price Target $8.75

Company Profile

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeuti...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 651 8867
Address:
One Kendall Square, 3rd Floor Building 1400 West, Cambridge, United States
theflynews
theflynews Mar. 11 at 4:23 PM
Biotech Alert: Searches spiking for these stocks today - $CAMP - https://thefly.com/CAMP
0 · Reply
NoMoneyPlayer
NoMoneyPlayer Mar. 11 at 5:28 AM
$CAMP Get onboard MF, going to be lit!!!!!
0 · Reply
Alien1980
Alien1980 Mar. 10 at 8:53 PM
$CAMP last mention from todays trades.. I wont bother posting the chart, but the move was from A1 PP 5.5 thru A2 6-6.3 and TP at the bottom of D1 PP 6.4 .9 per share light leverage cause low vol..
0 · Reply
topstockalerts
topstockalerts Mar. 10 at 8:33 PM
After Hours Top Gainers PT2 $CAMP $IPM $YAAS $WORX $BAER
0 · Reply
TheDude2778
TheDude2778 Mar. 10 at 12:55 PM
$CAMP —- any hope today even w 700 in volume … haha
0 · Reply
TheDude2778
TheDude2778 Mar. 10 at 7:15 AM
$CAMP —- There’s no way we are #3 in trading equity w no volume in AH/ and pretty much overnight trading sessions. Still holding and little intimated how this plays out today
0 · Reply
Liveforonce
Liveforonce Mar. 10 at 6:23 AM
$BATL $OLOX $XENE $CAMP if you have time, take a look at $NFE. They just had some interesting news that just came out and this could be the next runner. Good luck to all on your investments. Cheers!
1 · Reply
TheDude2778
TheDude2778 Mar. 10 at 6:05 AM
$CAMP — I guess if there’s no volume we might hold above $6
0 · Reply
StockScanners
StockScanners Mar. 10 at 4:02 AM
$CAMP keep watch if this holds above 5.91
1 · Reply
seriousrookie
seriousrookie Mar. 10 at 1:10 AM
$CAMP On High Watch for tomorrow.
1 · Reply
Latest News on CAMP
CAMP4 to Participate in Upcoming Investor Conferences

Mar 6, 2026, 4:05 PM EST - 9 days ago

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

Mar 5, 2026, 4:05 PM EST - 10 days ago

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 4:05 PM EST - 23 days ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 11:45 PM EST - 2 months ago

Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:00 AM EST - 2 months ago

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

Dec 18, 2025, 7:10 AM EST - 3 months ago

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

Dec 18, 2025, 7:00 AM EST - 3 months ago

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 12, 2025, 4:05 PM EST - 3 months ago

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

Nov 6, 2025, 4:05 PM EST - 4 months ago

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

Oct 1, 2025, 8:00 AM EDT - 5 months ago

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

Sep 10, 2025, 7:00 AM EDT - 6 months ago

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 7 months ago

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

May 16, 2025, 6:00 AM EDT - 10 months ago

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

May 13, 2025, 4:05 PM EDT - 10 months ago

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 11 months ago

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

Apr 10, 2025, 6:56 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

EWTX

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 27, 2025, 4:05 PM EDT - 1 year ago

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

Mar 18, 2025, 8:00 AM EDT - 1 year ago

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 10:39 PM EDT - 1 year ago

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 2:58 PM EDT - 1 year ago

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

Jan 7, 2025, 4:05 PM EST - 1 year ago

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Dec 2, 2024, 8:00 AM EST - 1 year ago

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

CAMP4 Reports Third Quarter 2024 Financial Results

Nov 21, 2024, 4:05 PM EST - 1 year ago

CAMP4 Reports Third Quarter 2024 Financial Results

CAMP4 Analyst Highlights Rare Disease Platform Potential

Nov 5, 2024, 3:06 PM EST - 1 year ago

CAMP4 Analyst Highlights Rare Disease Platform Potential

CAMP4 Announces Pricing of Initial Public Offering

Oct 10, 2024, 7:07 PM EDT - 1 year ago

CAMP4 Announces Pricing of Initial Public Offering

Camp4 Therapeutics Targets IPO On Early Positive Results

Oct 1, 2024, 4:30 PM EDT - 1 year ago

Camp4 Therapeutics Targets IPO On Early Positive Results

theflynews
theflynews Mar. 11 at 4:23 PM
Biotech Alert: Searches spiking for these stocks today - $CAMP - https://thefly.com/CAMP
0 · Reply
NoMoneyPlayer
NoMoneyPlayer Mar. 11 at 5:28 AM
$CAMP Get onboard MF, going to be lit!!!!!
0 · Reply
Alien1980
Alien1980 Mar. 10 at 8:53 PM
$CAMP last mention from todays trades.. I wont bother posting the chart, but the move was from A1 PP 5.5 thru A2 6-6.3 and TP at the bottom of D1 PP 6.4 .9 per share light leverage cause low vol..
0 · Reply
topstockalerts
topstockalerts Mar. 10 at 8:33 PM
After Hours Top Gainers PT2 $CAMP $IPM $YAAS $WORX $BAER
0 · Reply
TheDude2778
TheDude2778 Mar. 10 at 12:55 PM
$CAMP —- any hope today even w 700 in volume … haha
0 · Reply
TheDude2778
TheDude2778 Mar. 10 at 7:15 AM
$CAMP —- There’s no way we are #3 in trading equity w no volume in AH/ and pretty much overnight trading sessions. Still holding and little intimated how this plays out today
0 · Reply
Liveforonce
Liveforonce Mar. 10 at 6:23 AM
$BATL $OLOX $XENE $CAMP if you have time, take a look at $NFE. They just had some interesting news that just came out and this could be the next runner. Good luck to all on your investments. Cheers!
1 · Reply
TheDude2778
TheDude2778 Mar. 10 at 6:05 AM
$CAMP — I guess if there’s no volume we might hold above $6
0 · Reply
StockScanners
StockScanners Mar. 10 at 4:02 AM
$CAMP keep watch if this holds above 5.91
1 · Reply
seriousrookie
seriousrookie Mar. 10 at 1:10 AM
$CAMP On High Watch for tomorrow.
1 · Reply
TheDude2778
TheDude2778 Mar. 10 at 12:25 AM
$CAMP — I guess “if” we get 100 in volume we might get 6.86, fml
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 11:27 PM
Top Gainers PT2 $DTCK $RLMD $XENE $CAMP $SAFX
0 · Reply
TheDude2778
TheDude2778 Mar. 9 at 10:56 PM
$CAMP —- Anyone else holding overnight or am I the only dumb ass holding ? I accept my role
0 · Reply
BearTamerTrading
BearTamerTrading Mar. 9 at 10:27 PM
We were on fire today and caught these amazing plays as well 👉 $EDSA $EONR $ANTX $CAMP $GSIW and a few more! Congratulations to everyone who joined the stream today and to retail in general. Here is the replay for today’s live trading stream ⬇️ https://www.youtube.com/live/ZsrbHVgM9Dc?si=6lL1230dLf4iOwQi
4 · Reply
topstockalerts
topstockalerts Mar. 9 at 9:26 PM
Top Gainers PT2 $DTCK $RLMD $XENE $CAMP $SAFX
1 · Reply
GSP
GSP Mar. 9 at 8:38 PM
$SPY $IOT $CAMP $TDOC $GSIT
0 · Reply
StockJelli
StockJelli Mar. 9 at 8:22 PM
$ANTX faded to +83.9% later during the trading day and into the after hours. Let’s see if it’s a one day pump or not tomorrow. $QQQ $SPY $HIMS $CAMP
2 · Reply
Giulio9191
Giulio9191 Mar. 9 at 8:13 PM
$CAMP tomorrow 10 $
1 · Reply
topstockalerts
topstockalerts Mar. 9 at 7:55 PM
Top Gainers PT2 $SAFX $RLMD $CAMP $XENE $ACXP
1 · Reply
topstockalerts
topstockalerts Mar. 9 at 7:45 PM
$CAMP small caps continue to run..
1 · Reply
WallStreetBuyDip
WallStreetBuyDip Mar. 9 at 7:24 PM
Comparing trending tickers $CAMP vs $AGH: CAMP surged 56.43% to $6.57, trading hands at around 5.4M shares, which is well over 15 times its average volume. AGH also rose, up 13.11% to $5.52 with a trading volume of 28.0M shares, roughly 42 times its usual. While both stocks showed significant trading activity and price increases, CAMP's percentage gain was notably higher, suggesting stronger market enthusiasm compared to AGH, despite both having substantial volume increases.
0 · Reply
amishboy
amishboy Mar. 9 at 7:23 PM
$CAMP daytraders leave at 3:30 then we can resume the climb
1 · Reply